Proceedings of the American Thoracic Society Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Proceedings of the American Thoracic Society 3:461-465 (2006)
© 2006 The American Thoracic Society
doi: 10.1513/pats.200603-029MS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Celli, B. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Celli, B. R.

Roger S. Mitchell Lecture. Chronic Obstructive Pulmonary Disease Phenotypes and Their Clinical Relevance

Bartolome R. Celli

Caritas–St. Elizabeth's Medical Center; and Tufts University, Boston, Massachusetts

Correspondence and requests for reprints should be addressed to Bartolome R. Celli, M.D., Pulmonary and Critical Care Services, Caritas St. Elizabeth's Medical Center, 736 Cambridge Street, Boston, MA 02135. E-mail: bcelli{at}copdnet.org

ABSTRACT

Phenotype is defined as the outward physical manifestation of patients with chronic obstructive pulmonary disease (COPD); anything that is part of their observable structure, function, or behavior. As such, for patients with COPD, the time has come to move from a disease expressed solely by the degree of airflow limitation, to a much broader and resourceful characterization of COPD. Recent advances in the detection of specific clinical phenotypes, such as persistent hypoxemia, hyperinflation with inhomogeneous emphysema, frequent exacerbators, and patients with peripheral muscle dysfunction, are resulting in specific forms of approaches to include therapy that are affecting outcomes. Further, the investigation of the differential influence of gender on the development of COPD is finally catching our attention. In the area of basic science, we are beginning to understand different expressions of disease through genomics, proteomics, and metabonomics. Extensions of these findings and that of neglected aspects that may explain the clinical course of certain patients, such as their psychologic background, will certainly increase our understanding and provide more solid scientific rationale to the phenotypic characterization of patients with COPD. Further, such understanding will not only help explain the manifestations and course of the disease in particular patients but also help select for specific therapies. The hope is that, coupled with primary and secondary prevention, we can reverse the current epidemic and we can improve the well-being of patients affected by COPD.




This article has been cited by other articles:


Home page
Eur Respir JHome page
M. Weatherall, J. Travers, P. M. Shirtcliffe, S. E. Marsh, M. V. Williams, M. R. Nowitz, S. Aldington, and R. Beasley
Distinct clinical phenotypes of airways disease defined by cluster analysis
Eur. Respir. J., October 1, 2009; 34(4): 812 - 818.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Shaykhiev, A. Krause, J. Salit, Y. Strulovici-Barel, B.-G. Harvey, T. P. O'Connor, and R. G. Crystal
Smoking-Dependent Reprogramming of Alveolar Macrophage Polarization: Implication for Pathogenesis of Chronic Obstructive Pulmonary Disease
J. Immunol., August 15, 2009; 183(4): 2867 - 2883.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
D. A. Lomas, E. K. Silverman, L. D. Edwards, N. W. Locantore, B. E. Miller, D. H. Horstman, R. Tal-Singer, and on behalf of the Evaluation of COPD Longitudinally
Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD
Eur. Respir. J., July 1, 2009; 34(1): 95 - 102.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
M. Remy-Jardin and J. Remy
Vascular Disease in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, December 15, 2008; 5(9): 891 - 899.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
S E Marsh, J Travers, M Weatherall, M V Williams, S Aldington, P M Shirtcliffe, A L Hansell, M R Nowitz, A A McNaughton, J B Soriano, et al.
Proportional classifications of COPD phenotypes
Thorax, September 1, 2008; 63(9): 761 - 767.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
I Sabroe, L C Parker, P M A Calverley, S K Dower, and M K B Whyte
Pathological networking: a new approach to understanding COPD
Postgrad. Med. J., May 1, 2008; 84(991): 259 - 264.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
I. Sabroe, L. C Parker, P. M A Calverley, S. K Dower, and M. K B Whyte
Pathological networking: a new approach to understanding COPD
Thorax, August 1, 2007; 62(8): 733 - 738.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. T. Dransfield, G. R. Washko, M. G. Foreman, R. S. J. Estepar, J. Reilly, and W. C. Bailey
Gender Differences in the Severity of CT Emphysema in COPD
Chest, August 1, 2007; 132(2): 464 - 470.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
T. Yoshida and R. M. Tuder
Pathobiology of Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease
Physiol Rev, July 1, 2007; 87(3): 1047 - 1082.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Thoracic Society.